Aruna Bio, Inc., a leader in the development of neural exosomes for the treatment of neurodegenerative diseases, today announced the company has been awarded a Small Business Innovation Research (SBIR) Phase II grant by the National Institutes of Health in ...
Read More »NanoView Awarded Phase II SBIR grant to support development of innovative exosome characterization platform
NanoView Biosciences, an emerging leader in the field of exosome characterization, has been awarded a National Science Foundation Small Business Innovation Research Phase II grant in the amount of...
Read More »ZenBio, Inc. Awarded a Phase I SBIR Grant for Tuned Stem Cell Extracellular Vesicles as a Novel Chronic Wound Therapeutic
ZenBio, Inc. announced that it has been awarded a Phase I SBIR from the National Institutes on Aging to exploit stem cell-derived extracellular vesicles as a biologic-derived therapy for chronic non-healing wounds in the elderly. Chronic wounds, such as venous ...
Read More »